Sight for Life

Personalized Flow. IOP Control.

Designed to be the first-of-its-kind treatment that allows maximum IOP reduction for patients with moderate to severe glaucoma.

Aims to Deliver IOP Control
Personalized flow for evolving patient needs

Safety Without Sacrificing Efficacy
Intends to address gaps in treatments for patients with moderate to severe glaucoma

Established Delivery Technique
Approach provides predictable outcomes

Myra Vision, A Shifamed Portfolio Company, Closes $17M In Series A Financings
Company to accelerate development of the first-of-its-kind treatment for patients with moderate to severe glaucoma

Myra Medical, A Shifamed Portfolio Company, Closes $3M In Seed Financing
Company is innovating next-generation treatment for moderate to advanced glaucoma